TY  - JOUR
PY  - 2011//
TI  - New approaches to strengthen pharmacovigilance
JO  - Drug Discovery Today: Technologies
A1  - Arlett, P.R.
A1  - Kurz, X.
SP  - e15
EP  - e19
VL  - 8
IS  - 1
N2  - Until recently, pharmacovigilance was mainly based on spontaneous reports, which provide low evidence of risks associated with medicines. Today, the importance of the full spectrum of the evidence hierarchy is recognised. This article reviews new approaches and data sources used in pharmacovigilance and shows that individual case safety reports, observational data, clinical trials and meta-analyses have unique characteristics that complement each other for the overall benefit-risk evaluation of medicines. © 2011 Elsevier Ltd. All rights reserved.<p /> <p>Language: en</p>
LA  - en
SN  - 1740-6749
UR  - http://dx.doi.org/10.1016/j.ddtec.2011.03.003
ID  - ref1
ER  -